EE481 Cost-Effectiveness of Empagliflozin for Patients With Heart Failure Irrespective of Ejection Fraction in England
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.724
https://www.valueinhealthjournal.com/article/S1098-3015(22)02928-X/fulltext
Title :
EE481 Cost-Effectiveness of Empagliflozin for Patients With Heart Failure Irrespective of Ejection Fraction in England
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02928-X&doi=10.1016/j.jval.2022.09.724
First page :
Section Title :
Open access? :
No
Section Order :
10269